These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38482145)

  • 1. Tuberculosis - eliminating the latent killer.
    The Lancet Regional Health-Southeast Asia
    Lancet Reg Health Southeast Asia; 2024 Mar; 22():100385. PubMed ID: 38482145
    [No Abstract]   [Full Text] [Related]  

  • 2. Killer (FASL regulatory) B cells are present during latent TB and are induced by BCG stimulation in participants with and without latent tuberculosis.
    van Rensburg IC; Loxton AG
    Tuberculosis (Edinb); 2018 Jan; 108():114-117. PubMed ID: 29523310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the diversity of circulating natural killer cells between active tuberculosis and latent tuberculosis infection.
    Zhou Y; Lan H; Shi H; Wu P; Zhou Y
    Tuberculosis (Edinb); 2022 Jul; 135():102221. PubMed ID: 35660362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes Comorbidity.
    Kathamuthu GR; Kumar NP; Moideen K; Menon PA; Babu S
    J Immunol Res; 2022; 2022():2422790. PubMed ID: 35242883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliminating latent tuberculosis.
    Young DB; Gideon HP; Wilkinson RJ
    Trends Microbiol; 2009 May; 17(5):183-8. PubMed ID: 19375916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Njie GJ; Morris SB; Woodruff RY; Moro RN; Vernon AA; Borisov AS
    Am J Prev Med; 2018 Aug; 55(2):244-252. PubMed ID: 29910114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
    LoBue PA; Mermin JH
    Lancet Infect Dis; 2017 Oct; 17(10):e327-e333. PubMed ID: 28495525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent
    Paquin-Proulx D; Costa PR; Terrassani Silveira CG; Marmorato MP; Cerqueira NB; Sutton MS; O'Connor SL; Carvalho KI; Nixon DF; Kallas EG
    Front Immunol; 2018; 9():1394. PubMed ID: 29971068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccines: time to think about the next generation.
    Kaufmann SH
    Semin Immunol; 2013 Apr; 25(2):172-81. PubMed ID: 23706597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of ageing on natural killer cell function and potential consequences for health in older adults.
    Hazeldine J; Lord JM
    Ageing Res Rev; 2013 Sep; 12(4):1069-78. PubMed ID: 23660515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis testing through the ages: the search for a sleeping killer.
    Kestler B; Tyler SK
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L412-L419. PubMed ID: 35170334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigens of
    Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
    Front Immunol; 2020; 11():582414. PubMed ID: 33117393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes.
    Roy Chowdhury R; Vallania F; Yang Q; Lopez Angel CJ; Darboe F; Penn-Nicholson A; Rozot V; Nemes E; Malherbe ST; Ronacher K; Walzl G; Hanekom W; Davis MM; Winter J; Chen X; Scriba TJ; Khatri P; Chien YH
    Nature; 2018 Aug; 560(7720):644-648. PubMed ID: 30135583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the treatment of tuberculosis and latent tuberculosis infection.
    Blumberg HM; Leonard MK; Jasmer RM
    JAMA; 2005 Jun; 293(22):2776-84. PubMed ID: 15941808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global trends and gaps in research related to latent tuberculosis infection.
    Chaw L; Chien LC; Wong J; Takahashi K; Koh D; Lin RT
    BMC Public Health; 2020 Mar; 20(1):352. PubMed ID: 32183753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection.
    Esin S; Batoni G
    J Innate Immun; 2015; 7(1):11-24. PubMed ID: 25196698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ongoing challenge of latent tuberculosis.
    Esmail H; Barry CE; Young DB; Wilkinson RJ
    Philos Trans R Soc Lond B Biol Sci; 2014; 369(1645):20130437. PubMed ID: 24821923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory of Natural Killer Cells: A New Chance against
    Choreño Parra JA; Martínez Zúñiga N; Jiménez Zamudio LA; Jiménez Álvarez LA; Salinas Lara C; Zúñiga J
    Front Immunol; 2017; 8():967. PubMed ID: 28855906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis.
    Cai Y; Dai Y; Wang Y; Yang Q; Guo J; Wei C; Chen W; Huang H; Zhu J; Zhang C; Zheng W; Wen Z; Liu H; Zhang M; Xing S; Jin Q; Feng CG; Chen X
    EBioMedicine; 2020 Mar; 53():102686. PubMed ID: 32114394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.